ACADIAN ASSET MANAGEMENT LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,684
-11.7%
773,867
+18.2%
0.01%
-8.3%
Q2 2023$3,041
-4.2%
654,468
-4.8%
0.01%
-14.3%
Q1 2023$3,173
-30.1%
687,235
+22.3%
0.01%
-36.4%
Q4 2022$4,538
-99.9%
561,828
-11.1%
0.02%
+15.8%
Q3 2022$3,504,000
+1.7%
631,800
-4.5%
0.02%
+5.6%
Q2 2022$3,447,000
+76.2%
661,615
+177.8%
0.02%
+125.0%
Q1 2022$1,956,000
-8.5%
238,157
+65.7%
0.01%0.0%
Q4 2021$2,137,000
-37.9%
143,718
-21.2%
0.01%
-38.5%
Q3 2021$3,442,000
-16.8%
182,288
-18.1%
0.01%
-18.8%
Q2 2021$4,135,000
-23.5%
222,469
-6.3%
0.02%
-23.8%
Q1 2021$5,404,000
+107.1%
237,393
+97.6%
0.02%
+110.0%
Q4 2020$2,609,000
+104.6%
120,163
-5.3%
0.01%
+100.0%
Q3 2020$1,275,000
+75.6%
126,910
+35.6%
0.01%
+66.7%
Q2 2020$726,000
-20.0%
93,566
+5.2%
0.00%
-40.0%
Q1 2020$908,000
+81.2%
88,946
+95.7%
0.01%
+150.0%
Q4 2019$501,000
+79.6%
45,447
+48.0%
0.00%
+100.0%
Q3 2019$279,000
+170.9%
30,711
+239.0%
0.00%
Q2 2019$103,000
+1371.4%
9,058
+1365.7%
0.00%
Q1 2019$7,0006180.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$13,773,0003.47%
AJU IB Investment Co., Ltd. 175,000$1,439,0002.22%
Frazier Life Sciences Management, L.P. 1,776,479$14,603,0001.24%
First Light Asset Management, LLC 1,672,497$13,748,0001.21%
BVF INC/IL 3,447,946$28,342,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,732,400$30,680,0000.94%
Endurant Capital Management LP 296,508$2,437,0000.64%
Parkman Healthcare Partners LLC 199,846$1,643,0000.48%
Eventide Asset Management 2,708,975$22,268,0000.35%
Lombard Odier Asset Management (Switzerland) SA 391,024$3,214,0000.25%
View complete list of SUTRO BIOPHARMA INC shareholders